Inventor · disambiguated record
Neil Beeharry
Also filed as: BEEHARRY NEIL
11 granted patents·9 pending applications·37 citations·filing 2013–2020
88Inventor score
Files withAI THERAPEUTICS INC6LAM THERAPEUTICS INC6AL THERAPEUTICS INC3AI Therapeutics2CANCER RES INST2
Top patents by PatentIndex Score
20 records- 0190US10206910B2Apilimod for use in the treatment of renal cancerLAM THERAPEUTICS INC·Filed 2015·Granted Feb 19, 2019·10 cites·15 claims
- 0289US10799508B2Methods for treating cancer using HSP90 inhibitorsAI THERAPEUTICS INC·Filed 2018·Granted Oct 13, 2020·4 cites·12 claims
- 0388US10765682B2Apilimod for use in the treatment of melanomaLAM THERAPEUTICS INC·Filed 2015·Granted Sep 8, 2020·4 cites·11 claims
- 0487US11266654B2Apilimod compositions and methods for using sameAI THERAPEUTICS INC·Filed 2019·Granted Mar 8, 2022·2 cites·9 claims
- 0584US8927516B2Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancerCANCER RES INST·Filed 2013·Granted Jan 6, 2015·4 cites·8 claims
- 0682US10350213B2Methods for treating cancer using apilimodAI THERAPEUTICS INC·Filed 2016·Granted Jul 16, 2019·4 cites·4 claims
- 0782US10179135B2Apilimod compositions and methods for using sameLAM THERAPEUTICS INC·Filed 2015·Granted Jan 15, 2019·4 cites·18 claims
- 0881US10220051B2Combination of DNA repair inhibition with bendamustine or gemcitabine in the treatment of cancerINSTITUTE FOR CANCER RES·Filed 2014·Granted Mar 5, 2019·3 cites·12 claims
- 0976US9421203B2Sensitization of cancer cells to DNA damage by inhibiting kinases essential for DNA damage checkpoint controlCANCER RES INST·Filed 2014·Granted Aug 23, 2016·1 cites·21 claims
- 1073US10729694B2Anti-viral compositions containing PIKfyve inhibitors and use thereofAI THERAPEUTICS INC·Filed 2016·Granted Aug 4, 2020·1 cites·16 claims
- 1169US11166944B2Apilimod compositions and methods for using same in the treatment of renal cancerAI Therapeutics·Filed 2019·Granted Nov 9, 2021·0 cites·11 claims
- 1259US2020360397A1Anti-viral compositions containing pikfyve inhibitors and use thereofAI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1358US2019091229A1Therapeutic methods relating to hsp90 inhibitorsLAM THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1457US2020253979A1Therapeutic methods relating to hsp90 inhibitorsAI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1556US2021030759A1Method for treating cancer using hsp90 inhibitorsAL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1652US2019183902A1Apilimod Compositions and Methods for Using SameAL THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1750US2019201385A1Apilimod for use in the treatment of renal cancerAI Therapeutics·Filed 2018·Application pending·0 cites
- 1850US2021077500A1Pikfyve inhibitors for cancer therapyAL THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1942US2019015421A1Biomarkers for Treating Cancer with ApilimodLAM THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2035US2018078561A1Active metabolites of apilimod and uses thereofLAM THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →